Total Payments
$4,251
2024 Payments
$611.94
Companies
16
Transactions
79
Payment Breakdown by Category
Food & Beverage$4,246 (99.9%)
Education$5.26 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,246 | 78 | 99.9% |
| Education | $5.26 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,159 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $652.37 | 11 | $0 (2022) |
| Merck Sharp & Dohme LLC | $348.80 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $331.39 | 9 | $0 (2022) |
| Abbott Laboratories | $273.55 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $252.61 | 6 | $0 (2020) |
| Lilly USA, LLC | $237.44 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $206.83 | 3 | $0 (2019) |
| ABBVIE INC. | $187.74 | 3 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $187.05 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611.94 | 12 | AstraZeneca Pharmaceuticals LP ($305.81) |
| 2023 | $464.20 | 6 | Abbott Laboratories ($273.55) |
| 2022 | $804.60 | 14 | AstraZeneca Pharmaceuticals LP ($438.13) |
| 2021 | $298.46 | 8 | Janssen Pharmaceuticals, Inc ($101.98) |
| 2020 | $289.36 | 4 | AstraZeneca Pharmaceuticals LP ($120.00) |
| 2019 | $424.08 | 7 | Janssen Pharmaceuticals, Inc ($203.71) |
| 2018 | $518.78 | 12 | SANOFI-AVENTIS U.S. LLC ($176.36) |
| 2017 | $839.64 | 16 | Merck Sharp & Dohme Corporation ($198.39) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: VACCINE | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $39.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.05 | General |
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $78.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $7.30 | General |
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.67 | General |
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $118.73 | General |
| Category: Obesity | ||||||
| 02/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $267.14 | General |
| Category: Diabetes Care | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $35.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $118.71 | General |
| Category: Diabetes | ||||||
| 05/19/2023 | PBG PUERTO RICO LLC | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: Diabetes Care | ||||||
| 10/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PRIMARY CARE | ||||||
| 10/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $112.05 | General |
| Category: PRIMARY CARE | ||||||
| 08/18/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/27/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Edna Robles, MD
Dr. Edna Robles, MD is a General Practice healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497858401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edna Robles, MD has received a total of $4,251 in payments from pharmaceutical and medical device companies, with $611.94 received in 2024. These payments were reported across 79 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,246).
Ad
Practice Information
- Specialty General Practice
- Location San Juan, PR
- Active Since 09/06/2006
- Last Updated 10/09/2012
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1497858401
Products in Payments
- FARXIGA (Drug) $790.08
- INVOKANA (Drug) $325.21
- XARELTO (Drug) $301.98
- FREESTYLE LIBRE 3 (Device) $267.14
- JARDIANCE (Drug) $222.61
- NURTEC ODT (Drug) $208.06
- SOLIQUA (Drug) $197.14
- BEVESPI AEROSPHERE (Drug) $129.50
- GARDASIL (Biological) $118.78
- ZEPBOUND (Drug) $118.73
- BREZTRI (Drug) $118.71
- MOUNJARO (Drug) $118.71
- AJOVY (Biological) $112.50
- SHINGRIX (Biological) $106.84
- ZOSTAVAX (Biological) $100.47
- BEXSERO (Biological) $99.99
- RYBELSUS (Drug) $96.00
- STEGLATRO (Drug) $93.75
- UBRELVY (Drug) $78.70
- TOUJEO (Drug) $61.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in San Juan
Mr. Gregorio Cortes-Maisonet, Md, MD
General Practice — Payments: $388,110
General Practice $388,110
Dr. Victor Palmer, Md, MD
General Practice — Payments: $26,478
General Practice $26,478
Mr. Miguel Sosa-Padilla, Md, MD
General Practice — Payments: $25,218
General Practice $25,218
Dalitza Alvarez Valentin, M.d, M.D
General Practice — Payments: $11,112
General Practice $11,112
Roberto Unda Gomez, M.d, M.D
General Practice — Payments: $10,035
General Practice $10,035
Dr. Rene Echevarria-Cofino, M.d, M.D
General Practice — Payments: $9,402
General Practice $9,402